Authors:
PRESTON DF
SPICER JA
BARANCZUK RJ
SCHIEFELBEIN ML
BAXTER KG
REDICK ML
MARTIN NL
Citation: Df. Preston et al., LONG-TERM OUTCOMES OF 60 BREAST-CANCER PATIENTS EXAMINED WITH [16-ALPHA I-123] IODO-ESTRADIOL 17-BETA AND SPECT IMAGING, The Journal of nuclear medicine, 37(10), 1996, pp. 1800-1800
Authors:
SIEG KG
GAFFNEY GR
PRESTON DF
HELLINGS JA
Citation: Kg. Sieg et al., SPECT BRAIN IMAGING ABNORMALITIES IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER, Clinical nuclear medicine, 20(1), 1995, pp. 55-60
Authors:
ROBINSON RG
PRESTON DF
SCHIEFELBEIN M
BAXTER KG
Citation: Rg. Robinson et al., STRONTIUM-89 THERAPY FOR THE PALLIATION OF PAIN DUE TO OSSEOUS METASTASES, JAMA, the journal of the American Medical Association, 274(5), 1995, pp. 420-424
Authors:
PRESTON DF
SPICER JA
FABIAN C
BAXTER KG
BARANCZUK RJ
SCHIEFELBEIN ML
ROBINSON RG
Citation: Df. Preston et al., DETECTION OF BREAST-CANCER I-123 16-ALPHA ESTRADIOL-17-BETA (I-123E2)BY SPECT IMAGING, The Journal of nuclear medicine, 35(5), 1994, pp. 160000274-160000274
Citation: Kg. Baxter et al., TC-99M HMPAC FOR CEREBRAL PERFUSION MAPPING DURING INTERVENTIONAL NEURORADIOLOGY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000275-160000275
Citation: Kg. Baxter et al., THE HEPATOPULMONARY SHUNT SYNDROME - NUCLEAR MEDICINES ROLE IN EVALUATION, The Journal of nuclear medicine, 35(5), 1994, pp. 160000275-160000275